Clinical Trials Directory

Trials / Unknown

UnknownNCT00674934

Far Infrared Irradiation for Managing and Treating Multiple Sclerosis (MS)

Phase 1 Study to Determine the Efficacy of Using Far Infrared Radiation for Multiple Sclerosis.

Status
Unknown
Phase
Phase 1
Study type
Interventional
Enrollment
5 (estimated)
Sponsor
GAAD Medical Research Institute Inc. · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Multiple sclerosis (abbreviated MS) is an autoimmune condition in which the immune system attacks the central nervous system (CNS), leading to demyelination. This study will investigate the use of far infrared radiation for MS control, management and treatment.

Detailed description

MS a demyelinating disease, is any disease of the nervous system in which the myelin sheath of neurons is damaged. This impairs the conduction of signals in the affected nerves, causing impairment in sensation, movement, cognition, or other functions depending on which nerves are involved. MS affects the areas of the brain and spinal cord known as the white matter. White matter cells carry signals between the grey matter areas, where the processing is done, and the rest of the body. More specifically, MS destroys oligodendrocytes which are the cells responsible for creating and maintaining a fatty layer, known as the myelin sheath, which helps the neurons carry electrical signals. Observations from our research studies indicate that, far infrared rays provide energy to the body, improve the autonomic functions of the nervous system, restore the functions of the endocrine system, strengthen the immune system, improve blood circulation and increase the level of oxygen in the cells and promote the regeneration of muscle cells, nerves and brain cells. It is hereby postulated that irradiation using far infrared, with wavelength between 5 to 20 microns, of the central nervous system, the endocrine system and the whole body could prevent, control, manage or possibly lead to complete rehabilitation of people who have MS.

Conditions

Interventions

TypeNameDescription
RADIATIONFar Infrared Radiation (5μm to 20μm wavelength)Far Infrared Radiation (5μm to 20μm wavelength). Far Infrared radiation for 30 to 40 minutes per treatment session.

Timeline

Start date
2008-05-01
Primary completion
2010-05-01
Completion
2010-06-01
First posted
2008-05-08
Last updated
2009-01-05

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00674934. Inclusion in this directory is not an endorsement.

Far Infrared Irradiation for Managing and Treating Multiple Sclerosis (MS) (NCT00674934) · Clinical Trials Directory